Studying how well honey works when applied to the mouth to treat mouth sores caused by radiation in patients with head and neck cancer admitted in AVBRH Hospital

Assess the effectiveness of topical application of honey in the management of radiation induced oral mucositis among the head and neck cancers patient admitted in AVBRH hospital - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091959

Enrollment

Registered

2025-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C040- Malignant neoplasm of anterior floor of mouth

Interventions

Intervention1: Nil: Nil Intervention2: Topical Application: Honey is being used in topical application to reduce mucositis Control Intervention1: Honey: It is topical application applied at the patien

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adults aged 18 to 60 yr. 2.Diagnosed with head and neck cancers undergoing radiotherapy. 3.Development of radiation-induced oral mucositis (grade 2 or higher).

Exclusion criteria

Exclusion criteria: 1.History of allergic reactions to honey. 2.Patients with pre-existing severe oral conditions (e.g., advanced periodontal disease or active infections). 3.Individuals with compromised immune systems (e.g., uncontrolled diabetes or active chemotherapy).

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of topical honey application in reducing the incidence and severity of radiation-induced oral mucositis in patients undergoing head and neck cancer treatment.Timepoint: 3 weeks	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Ruchira Ankar

Datta Meghe Institute Of Higher Education And Research

ruchira3110@gmail.com7620978673

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026